Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

This study has been completed.
Information provided by (Responsible Party):
Dr . BONAVENTURA CLOTET, Germans Trias i Pujol Hospital Identifier:
First received: March 3, 2006
Last updated: September 15, 2016
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)